Search

everythinglearnresearchcommunity

for

Search:↓

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Bimekizumab can improve scarring alopecia in severe psoriasis.

Bimekizumab effectively treated a man's chronic beard hair loss.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

Secukinumab reduces immune activity in hidradenitis suppurativa skin.

Minoxidil rejuvenates hair follicles and reduces aging signs in male pattern baldness.

Minoxidil helps hair regrowth and has anti-aging effects on hair follicles.

Hair follicles are crucial for maintaining skin barrier function.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Higher Interleukin 17A levels may indicate more severe alopecia areata.

The document concludes that a new method has been developed to test anti-aging substances on human skin, showing that these substances can reduce skin aging signs.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Azathioprine may help with severe hair loss, a new topical treatment could counteract hair thinning, and trichoscopy can diagnose hair-pulling disorder effectively.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

Finasteride was successfully synthesized from Pregnadienolone acetate.

PCOS causes inflammation regardless of body weight.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

The chemicals 17βC and its methyl ester can block the effects of testosterone on hamster skin but not the effects of DHT.

The compound was successfully made and shows potential for treating prostate cancer.

Analog 23 is a promising compound for prostate cancer treatment.

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.